October 2026: US Judge Pauses Altria Lawsuit as FDA Reconsiders Tobacco Product Review Framework A US federal judge has temporarily paused a lawsuit brought by Altria-affiliated companies challenging the Food and Drug Administration’s (FDA) premarket review framework for tobacco products, following the agency’s announcement that it intends to evaluate potential

Patent wars, long associated with the technology and software sectors, refer to legal battles between companies seeking to protect, challenge, or leverage intellectual property rights. The tobacco industry’s rapid transition toward reduced-risk products has triggered a similar wave of patent disputes in recent years, particularly since 2018, with no clear

Patent wars, long associated with the technology and software sectors, refer to legal battles between companies seeking to protect, challenge, or leverage intellectual property rights. The tobacco industry’s rapid transition toward reduced-risk products has triggered a similar wave of patent disputes in recent years, particularly since 2018, with no clear

September 2026: British American Tobacco Faces Third UK Investor Claim Over Historical North Korea Disclosures British American Tobacco (BAT) is facing a third UK shareholder lawsuit in the High Court of England and Wales over allegations that it failed to adequately disclose its historical North Korean operations and associated sanctions

August 2026: JUUL Labs and Altria Appeal B.C. Court Decision Certifying Mass Class Action JUUL Labs and Altria Group have launched a formal appeal against a British Columbia court decision that certified a nationwide class-action lawsuit accusing the companies of deceptively marketing vaping products to Canadian consumers. The companies filed